✦ LIBER ✦

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

✍ Scribed by Brodowicz, Thomas; Krzakowski, Maciej; Zwitter, Matjaz; Tzekova, Valentina; Ramlau, Rodryg; Ghilezan, Nicolae; Ciuleanu, Tudor; Cucevic, Branka; Gyurkovits, Kalman; Ulsperger, Ernst; Jassem, Jacek; Grgic, Mislav; Saip, Pinar; Szilasi, Maria; Wiltschke, Christoph; Wagnerova, Maria; Oskina, Natalya; Soldatenkova, Victoria; Zielinski, Christoph; Wenczl, Miklos

Book ID: 119319362
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 237 KB
Volume: 52
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2006.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line gemcitabine with cisplatin or

First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial

✍ Wachters, F M; van Putten, J W G; Kramer, H; Erjavec, Z; Eppinga, P; Strijbos, J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

First-Line Erlotinib Followed by Second-

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The TORCH Randomized Trial

✍ Gridelli, C.; Ciardiello, F.; Gallo, C.; Feld, R.; Butts, C.; Gebbia, V.; Maione 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 259 KB

Gemcitabine, vinorelbine and cisplatin c

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial

✍ E Laack; T Mende; H Dürk; M Kneba; N Dickgreber; T Welte; T Müller; J Scholtze; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Gemcitabine and vinorelbine as first-lin

Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

✍ E Laack; T Mende; J Benk; A Chemaissani; J Scholtze; C Lorenz; A Niestroy; K Dal 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 144 KB

An International, Multicenter, Randomize

An International, Multicenter, Randomized Phase III Study of First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Versus First-Line Cisplatin/Gemcitabine Followed by Second-Line Erlotinib in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics of the TORCH Trial

✍ Cesare Gridelli; Charles Butts; Fortunato Ciardiello; Ronald Feld; Ciro Gallo; F 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 91 KB

Gemcitabine—Cisplatin chemotherapy follo

Gemcitabine—Cisplatin chemotherapy followed by radiotherapy in locally advanced non-small cell lung cancer (nsclc): A phase II retrospective analysis

✍ Crinò, L; De Marinis, F; Scagliotti, G; Rinaldi, M; Maestri, A; Mazzoni, F; Di S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 145 KB